Matthew Maxwell Donley - 21 Nov 2022 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Ex VP, Internal Operations
Signature
/s/ Matthew Maxwell Donley
Issuer symbol
AUPH
Transactions as of
21 Nov 2022
Net transactions value
+$46,600
Form type
4
Filing time
23 Nov 2022, 15:04:04 UTC
Previous filing
04 Mar 2022
Next filing
06 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Purchase $46,600 +10,000 +56% $4.66 27,927 21 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,703 common stock of the Issuer acquired by the reporting person on May 31, 2022 pursuant to the Company's 2021 Employee Stock Purchase Plan.